HER3-Targeted Therapies for EGFRm NSCLC: Key Evidence and Real-world Insights to Optimize Patient Care

Enhance your knowledge of HER3 overexpression in EGFR-mutated non-small-cell lung cancer and gain strategies for developing individualized treatment plans incorporating HER3-targeted therapies in patients with acquired resistance to EGFR tyrosine kinase inhibitors, through a series of text modules with accompanying downloadable slidesets and an expert-authored commentary.

Share

Program Content

Activities

HER3 EGFRm NSCLC Care
HER3-Targeted Therapies for EGFRm NSCLC: Emerging Therapies and Challenges in Treatment
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: October 09, 2024

Expires: October 08, 2025

Activities

NSCLC HER3 AE Management
Optimizing HER3-Targeted Therapy for NSCLC: Strategies for Early Detection and Management of Adverse Events 
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: December 05, 2024

Expires: June 04, 2025

Novel HER3 Agents for EGFR Mutated NSCLC
New Frontiers in Advanced EGFR-Mutated NSCLC Therapy: Targeting HER3 With Novel Agents
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: December 17, 2024

Expires: June 16, 2025

Activities

NSCLC HER3 AE Management
Optimizing HER3-Targeted Therapy for NSCLC: Strategies for Early Detection and Management of Adverse Events
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: December 05, 2024

Expires: December 04, 2025

Novel HER3 Agents for EGFR-Mutated NSCLC
New Frontiers in Advanced EGFR-Mutated NSCLC Therapy: Targeting HER3 With Novel Agents
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: December 17, 2024

Expires: December 16, 2025

Faculty

cover img faculity

Karen Reckamp, MD, MS

Director, Division of Medical Oncology
Associate Director, Clinical Research
Professor, Department of Medicine
Cedars-Sinai Medical Center
Los Angeles, California

cover img faculity

Helena Yu, MD

Associate Attending
Research Director
Thoracic Oncology Service
Memorial Sloan Kettering Cancer Center
New York, New York

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by an educational grant from Daiichi Sankyo, Inc.

Daiichi Sankyo, Inc.